CClinicalTrials.gg
CompletedNCT03307694Updated Dec 3, 2019

Thyroid Ultrasound Elasticity (TrUE) Imaging

An observational study in Cancer, Thyroid, sponsored by Emory University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-12-03.

Sponsored by Emory University · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
31
Ages
18 Years and older
Sex
All
01

Study summary

In this study the researchers will scan the thyroid nodules of patients scheduled for surgical removal of these nodules. During their preadmission testing, but prior to their surgery, the researchers will perform standard ultrasound and shear wave elasticity imaging (SWEI) scans of the thyroid nodules in these patients. Both images can be generated by the same ultrasound scanner and within the same imaging session without having to switch out any equipment. The results of the SWEI scans will be compared to the definitive diagnosis from pathology obtained after pathologists have examined the removed nodules post-operatively.

Read the detailed description

Thyroid ultrasound is a first-line procedure to assess patients with thyroid nodules. Unfortunately, standard ultrasound has low sensitivity, and thus low positive predictive value, for malignancy and many patients with thyroid nodules are referred for additional imaging studies or biopsy. Shear wave elasticity imaging (SWEI) is a non-invasive ultrasound technology that allows clinicians to assess the stiffness of tissues. In many solid tumors, increased stiffness is highly specific for underlying malignancy, and preliminary studies have shown this to be true for thyroid malignancies. Both standard sonography and SWEI can be performed on the same ultrasound equipment and within the same imaging session. Therefore, integrating SWEI into standard thyroid diagnostic workflow is a logical approach towards improving the positive predictive value of these first-line sonographic studies. Other studies have demonstrated the ability of SWEI techniques to differentiate benign from malignant thyroid nodules. However, shear wave techniques still need to overcome challenges before they can be successfully integrated into the clinical paradigm. These techniques still struggle to accurately classify follicular carcinomas and few have been validated in patients with multiple thyroid lesions, a scenario which is clinically common. The researchers believe that a multi-angle compound SWEI (MAC-SWEI) algorithm, which generates shear images based on multiple angled push beams, has the potential to generate more accurate shear wave images in the context of thyroid imaging. To this end, this study will perform proof-of-concept studies of MAC-SWEI in thyroid patients undergoing standard ultrasound scans and compare the results of shear wave images to results from corresponding pathology.

Study participants will undergo a single SWEI session within their normally-scheduled preadmission testing during which both standard b-mode and shear images of the thyroid nodule(s) will be acquired. The 36 patients will be randomized to receive MAC-SWEI, standard SWEI, and ultrasound, or only standard SWEI and ultrasound.

02

Conditions studied

  • Cancer, Thyroid

Keywords

  • Cancer
  • Thyroid nodule
  • Imaging
  • Radiology
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Study participants will be recruited from patients of the Emory Healthcare system who are scheduled to have a thyroid biopsy, thyroidectomy, or cervical node biopsy.

Inclusion criteria

  • Age ≥ 18 years old
  • Scheduled to undergo a thyroid biopsy, thyroidectomy, or cervical node biopsy

Exclusion criteria

Exclusion Criteria:

  • None
04

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
31 participants (actual)
Patient registry
No

Groups and cohorts

  • MAC-SWEI, standard SWEI, ultrasound

    Participants in this group will receive all three imaging techniques

    Diagnostic Test: Ultrasound · Diagnostic Test: Shear wave elasticity imaging · Diagnostic Test: Multi-angle compound shear wave elasticity imaging

  • Standard SWEI, ultrasound

    Participants in this group will receive two imaging techniques

    Diagnostic Test: Ultrasound · Diagnostic Test: Shear wave elasticity imaging

Interventions

  • Diagnostic testUltrasound

    All ultrasound images will be acquired by an in-house ultrasound technologist using a Verasonics Vantage (Verasonics Inc., Kirkland, Washington, USA) ultrasound system. During imaging, the technologist will position the Verasonics transducer, under b-mode guidance, in planes overlying the thyroid nodules approximating those obtained during previous clinical ultrasound scans.

  • Diagnostic testShear wave elasticity imaging

    Shear wave elasticity imaging (SWEI) is obtained during the standard ultrasound session. The generation of shear wave images consists of two important steps called "pushing" and "tracking". First, in the "pushing" mode, a long focused ultrasound beam is transmitted to perturb tissue, generating ultrasonic shear waves in tissue that propagate perpendicular to the direction of pushing. In the "tracking" mode, shear wave propagation is observed and recorded. Because the speed of shear waves is a function of Young's modulus, these data reveal information about the stiffness of underlying biological tissue.

    Also known as: SWEI

  • Diagnostic testMulti-angle compound shear wave elasticity imaging

    The multi-angle compound SWEI (MAC-SWEI) algorithm, which generates shear images based on multiple angled push beams, has the potential to generate more accurate shear wave images in the context of thyroid imaging. To assess the MAC-SWEI technique, shear wave images will be used to generate estimates of the relative stiffness of lesions via their normalized Young's modulus.

    Also known as: MAC-SWEI

05

What researchers measure

Primary outcomes

  1. Determination of Malignancy by SWEI Imaging

    As part of the pre-operative visit, participants will have imaging of their thyroid nodules. Established SWEI and MAC-SWEI techniques will be performed to identify malignant thyroid tissue.

    Time frame: Pre-operative visit (within 24 hours before surgery, on average)

  2. Determination of Malignancy by Pathological Proof

    Tissue samples obtained during the participant's thyroid biopsy, thyroidectomy, or cervical node biopsy will be submitted to the pathology lab as part of the clinical standard of care. The pathology report will specify whether or not malignant cells were found in the tissue sample.

    Time frame: Post-surgery (within 10 days after surgery, on average)

Secondary outcomes

  1. Accuracy of differentiating benign from malignant lesions between SWEI techniques

    The ability of MAC-SWEI to differentiate benign from malignant lesions will be compared to the ability of standard SWEI to make this differentiation.

    Time frame: Pre-operative visit (within 24 hours before surgery, on average)

06

Study locations

1 site
  • Emory Univeristy Hospital Midtown
    Atlanta, Georgia 30308, United States
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03307694
Lead sponsor
Emory University
Responsible party
Stanislav Emelianov (Adjunct Professor, Emory University) — Principal investigator
First posted
Oct 12, 2017
Start date
Oct 23, 2017
Primary completion
Jul 13, 2018
Completion
Jul 13, 2018
Last update
Dec 3, 2019

Study contacts

Stanislav Emelianov, PhD
principal investigator · Emory University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion